GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.

Autor: Liu I; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, 10117 Berlin, Germany., Alencastro Veiga Cruzeiro G; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Bjerke L; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Rogers RF; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Grabovska Y; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Beck A; Center for Neuropathology, Ludwig-Maximilians-University, 81377 Munich, Germany., Mackay A; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Barron T; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA., Hack OA; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Quezada MA; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA., Molinari V; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Shaw ML; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Perez-Somarriba M; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, Surrey SM2 5 NG, UK., Temelso S; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK., Raynaud F; Division of Cancer Therapeutics, The Institute of Cancer Research, London SW7 3RK, UK., Ruddle R; Division of Cancer Therapeutics, The Institute of Cancer Research, London SW7 3RK, UK., Panditharatna E; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Englinger B; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria; Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Mire HM; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Jiang L; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Nascimento A; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., LaBelle J; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Haase R; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Rozowsky J; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Neyazi S; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Baumgartner AC; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Castellani S; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Hoffman SE; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Cameron A; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Morrow M; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Pericoli G; Department of Onco-haematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, 00165 Rome, Italy., Madlener S; Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Mayr L; Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Dorfer C; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria., Geyeregger R; Clinical Cell Biology, Children's Cancer Research Institute (CCRI), Vienna 1090, Austria., Rota C; Department of Neurobiology, Harvard Medical School, Boston, MA 02215, USA., Ricken G; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna 1090, Austria., Ligon KL; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA; Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA., Alexandrescu S; Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA., Cartaxo RT; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA., Lau B; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA., Uphadhyaya S; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA., Koschmann C; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA., Braun E; Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden., Danan-Gotthold M; Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden., Hu L; Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden., Siletti K; Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden., Sundström E; Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, 17177 Stockholm, Sweden., Hodge R; Allen Institute for Brain Science, Seattle, WA 98109, USA., Lein E; Allen Institute for Brain Science, Seattle, WA 98109, USA., Agnihotri S; Departments of Neurosurgery and Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA., Eisenstat DD; Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Parkville, VIC 3052, Australia., Stapleton S; Department of Neurosurgery, St George's Hospital NHS Trust, London SW17 0QT, UK., King A; Department of Neuropathology, King's College Hospital NHS Trust, London SE5 9RS, UK., Bleil C; Department of Neurosurgery, King's College Hospital NHS Trust, London SE5 9RS, UK., Mastronuzzi A; Department of Onco-haematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, 00165 Rome, Italy., Cole KA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Waanders AJ; Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA., Montero Carcaboso A; Laboratory of Molecular Oncology, Hospital Sant Joan de Déu, 08950 Barcelona, Spain., Schüller U; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany., Hargrave D; University College London Great Ormond Street Institute for Child Health, London WC1N 1EH, UK., Vinci M; Department of Onco-haematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, 00165 Rome, Italy., Carceller F; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, Surrey SM2 5 NG, UK; Division of Clinical Studies, The Institute of Cancer Research, London SW7 3RK, UK., Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna 1090, Austria., Slavc I; Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Linnarsson S; Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden., Gojo J; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Monje M; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford, CA, USA., Jones C; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5 NG, UK. Electronic address: chris.jones@icr.ac.uk., Filbin MG; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: mariella.filbin@childrens.harvard.edu.

Publikováno v: Cancer cell [Cancer Cell] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.

Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.

Autor: Pericoli G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Galardi A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Paolini A; Multifactorial and Complex Phenotype Research Area, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Petrilli LL; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pepe G; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Palma A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Colletti M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Ferretti R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Giorda E; Core Facilities research laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Levi Mortera S; Multimodal Laboratory Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Burford A; Department of Molecular Pathology, The Institute of Cancer Research, Sutton, UK., Carai A; Oncological Neurosurgery Unit, Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Mastronuzzi A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Mackay A; Department of Molecular Pathology, The Institute of Cancer Research, Sutton, UK., Putignani L; Multimodal Laboratory Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Jones C; Department of Molecular Pathology, The Institute of Cancer Research, Sutton, UK., Pascucci L; Department of Veterinary Medicine, University of Perugia, Perugia, Italy., Peinado H; Microenvironment & Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Helmer-Citterich M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., de Billy E; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Masotti A; Multifactorial and Complex Phenotype Research Area, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Locatelli F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Di Giannatale A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Vinci M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy. maria.vinci@opbg.net.

Publikováno v: Cell & bioscience [Cell Biosci] 2023 Nov 13; Vol. 13 (1), pp. 207. Date of Electronic Publication: 2023 Nov 13.

Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry.

Autor: Petrilli LL; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital- IRCCS, Rome, Italy., Fuoco C; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Palma A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital- IRCCS, Rome, Italy., Pasquini L; Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Pericoli G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital- IRCCS, Rome, Italy., Grabovska Y; Division of Molecular Pathology, Institute of Cancer Research, Sutton, United Kingdom., Mackay A; Division of Molecular Pathology, Institute of Cancer Research, Sutton, United Kingdom., Rossi S; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Carcaboso AM; Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, Barcelona, Spain., Carai A; Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital -IRCCS, Rome, Italy., Mastronuzzi A; Neuro-oncology Unit, Department of Onco-haematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Jones C; Division of Molecular Pathology, Institute of Cancer Research, Sutton, United Kingdom., Cesareni G; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Locatelli F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital- IRCCS, Rome, Italy., Vinci M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital- IRCCS, Rome, Italy.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Dec 08; Vol. 12, pp. 1016343. Date of Electronic Publication: 2022 Dec 08 (Print Publication: 2022).

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Autor: de Billy E; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pellegrino M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Orlando D; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pericoli G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Ferretti R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Businaro P; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Ajmone-Cat MA; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità-Rome, Rome, Italy., Rossi S; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Petrilli LL; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Maestro N; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Diomedi-Camassei F; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pezzullo M; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., De Stefanis C; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Bencivenga P; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Palma A; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Rota R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Del Bufalo F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Massimi L; Department of Pediatric Neurosurgery, Catholic University Medical School, Rome, Italy., Weber G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Jones C; Division of Molecular Pathology, Institute of Cancer Research, Sutton, UK., Carai A; Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Caruso S; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., De Angelis B; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Caruana I; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Quintarelli C; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Mastronuzzi A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Locatelli F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Pediatrics, Sapienza University of Rome, Rome, Italy., Vinci M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.

Publikováno v: Neuro-oncology [Neuro Oncol] 2022 Jul 01; Vol. 24 (7), pp. 1150-1163.

DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition.

Autor: Izquierdo E; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Carvalho DM; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Mackay A; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Temelso S; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Boult JKR; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Pericoli G; Department of Haematology/Oncology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Fernandez E; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Das M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Molinari V; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Grabovska Y; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Rogers RF; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Ajmone-Cat MA; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Proszek PZ; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Stubbs M; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom., Depani S; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., O'Hare P; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Yu L; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Roumelioti G; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Choudhary JS; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Clarke M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Fairchild AR; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Jacques TS; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Grundy RG; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Howell L; Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., Picton S; Leeds Children's Hospital, Leeds, United Kingdom., Adamski J; Birmingham Women's and Children's Hospital, Birmingham, United Kingdom., Wilson S; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Gray JC; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Zebian B; Department of Neurosurgery, Kings College Hospital NHS Trust, London, United Kingdom., Marshall LV; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Carceller F; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Grill J; Department of Pediatric and Adolescent Oncology and INSERM Unit U891, Team 'Genomics and Oncogenesis of Pediatric Brain Tumors,' Gustave Roussy and University Paris-Saclay, Villejuif, France., Vinci M; Department of Haematology/Oncology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Hubank M; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Hargrave D; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Jones C; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.

Publikováno v: Cancer discovery [Cancer Discov] 2022 Mar 01; Vol. 12 (3), pp. 712-729.